Comparison between Deem Roll Tech IPO and Zenith Drugs IPO.
IPO Details
Deem Roll Tech IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Deem Roll Tech IPO is up to ₹27.79 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Deem Roll Tech IPO is ₹129.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
IPO Timetable
Deem Roll Tech IPO opens on Feb 20, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Deem Roll Tech IPO and Zenith Drugs IPO is Feb 22, 2024, and Feb 22, 2024, respectively.
| | Deem Roll Tech IPO | Zenith Drugs IPO |
|---|
| Anchor Bid Date | | Feb 16, 2024 |
| Issue Open | Feb 20, 2024 | Feb 19, 2024 |
| Issue Close | Feb 22, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Feb 23, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Feb 26, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Feb 26, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Feb 27, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | | Mar 24, 2024 |
| Anchor Lockin End date 2 | | May 23, 2024 |
Financials & KPIs
Deem Roll Tech IPO P/E ratio is 11.31, as compared to Zenith Drugs IPO P/E ratio of 18.4.
Shares Offered
In the Deem Roll Tech IPO Retail Individual Investors (RII) are offered 10,77,000 shares while in Zenith Drugs IPO retail investors are offered 10,77,000 shares. Qualified Institutional Buyers (QIB) are offered in Deem Roll Tech IPO and 8,59,200 shares in Zenith Drugs IPO.
| | Deem Roll Tech IPO | Zenith Drugs IPO |
|---|
| Anchor Investor Reservation | | 12,88,000 shares |
| Market Maker Reservation | 1,14,000 shares | 8,52,800 shares |
| QIB | | 8,59,200 shares |
| NII | 10,77,000 shares | 6,44,800 shares |
| RII | 10,77,000 shares | 15,04,000 shares |
| Employee | | |
| Others | | |
| Total | 21,54,000 shares | 42,96,000 shares |
Bids Received (Subscription)
Deem Roll Tech IPO subscribed 256.55x in total, whereas Zenith Drugs IPO subscribed 179.18x.
